Published October 14, 2023 | Version v1
Journal article Open

Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City

Description

(1) Background: With increasing international travel and mass population displacement due to war, famine, climate change, and immigration, pathogens, such as Staphylococcus aureus (S. aureus), can also spread across borders. Methicillin-resistant S. aureus (MRSA) most commonly causes skin and soft tissue infections (SSTIs), as well as more invasive infections. One clonal strain, S. aureus USA300, originating in the United States, has spread worldwide. We hypothesized that S. aureus USA300 would still be the leading clonal strain among US-born compared to non-US-born residents, even though risk factors for SSTIs may be similar in these two populations (2) Methods: In this study, 421 participants presenting with SSTIs were enrolled from six community health centers (CHCs) in New York City. The prevalence, risk factors, and molecular characteristics for MRSA and specifically clonal strain USA300 were examined in relation to the patients' self-identified country of birth. (3) Results: Patients born in the US were more likely to have S. aureus SSTIs identified as MRSA USA300. While being male and sharing hygiene products with others were also significant risks for MRSA SSTI, we found exposure to animals, such as owning a pet or working at an animal facility, was specifically associated with risk for SSTIs caused by MRSA USA300. Latin American USA300 variant (LV USA300) was most common in participants born in Latin America. Spatial analysis showed that MRSA USA300 SSTI cases were more clustered together compared to other clonal types either from MRSA or methicillin-sensitive S. aureus (MSSA) SSTI cases. (4) Conclusions: Immigrants with S. aureus infections have unique risk factors and S. aureus molecular characteristics that may differ from US-born patients. Hence, it is important to identify birthplace in MRSA surveillance and monitoring. Spatial analysis may also capture additional information for surveillance that other methods do not.

Data availability

De-identified data may be available upon written request to the Principal Investigator (jntobin@cdnetwork.org) and execution of a data usage agreement.

Files

antibiotics-12-01541-v2.pdf

Files (2.8 MB)

Name Size Download all
md5:86f1d6536d475520b4f4cadaa148873a
181.2 kB Preview Download
Article
md5:6e8b4a6712a89abc32c7aa71ebde2203
2.7 MB Preview Download

Additional details

Identifiers

DOI
10.3390/antibiotics12101541
Other
oai:uchicago.tind.io:14836

Funding

Patient-Centered Outcomes Research Institute
CER-1402-10800
National Center for Advancing Translational Sciences
UL1 TR001866
Center of Excellence
N2: Building a Network of Safety Net PBRNs
National Institutes of Health
UL1TR002378
National Institutes of Health
G12-RR03034
National Institutes of Health
HS024338-01
National Library of Medicine
G08LM013190-0

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pediatrics